![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | decreases expression | ISO | RGD:737418 | 6480464 | Demecolcine results in decreased expression of P2RX5 mRNA | CTD | PMID:23649840 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of P2RX5 mRNA | CTD | PMID:19484750 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:737418 | 6480464 | Tetrachlorodibenzodioxin affects the expression of P2RX5 mRNA | CTD | PMID:22298810 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | EXP | | 6480464 | tetrabromobisphenol A results in decreased expression of P2RX5 mRNA | CTD | PMID:25172293 | 4-hydroxynon-2-enal | decreases expression | ISO | RGD:737418 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of P2RX5 mRNA | CTD | PMID:12419474 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of P2RX5 mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | decreases expression | ISO | RGD:737418 | 6480464 | Tretinoin results in decreased expression of P2RX5 mRNA | CTD | PMID:23724009 | ammonium chloride | affects expression | ISO | RGD:620256 | 6480464 | Ammonium Chloride affects the expression of P2RX5 mRNA | CTD | PMID:16483693 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzoapyrene results in increased expression of P2RX5 mRNA | CTD | PMID:21569818 | benzo[a]pyrene | decreases methylation | ISO | RGD:737418 | 6480464 | Benzoapyrene results in decreased methylation of P2RX5 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | RGD:737418 | 6480464 | Benzoapyrene results in increased expression of P2RX5 mRNA | CTD | PMID:20106945 more ... | benzo[b]fluoranthene | increases expression | EXP | | 6480464 | benzobfluoranthene results in increased expression of P2RX5 mRNA | CTD | PMID:26377693 | bisphenol A | decreases expression | ISO | RGD:620256 | 6480464 | bisphenol A results in decreased expression of P2RX5 mRNA | CTD | PMID:25181051 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of P2RX5 mRNA | CTD | PMID:24982889 | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes, Carbon analog results in decreased expression of P2RX5 mRNA | CTD | PMID:25554681 | cisplatin | multiple interactions | ISO | RGD:737418 | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of P2RX5 mRNA | CTD | PMID:27392435 | cisplatin | decreases expression | ISO | RGD:737418 | 6480464 | Cisplatin results in decreased expression of P2RX5 mRNA | CTD | PMID:27392435 | copper atom | multiple interactions | ISO | RGD:737418 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of P2RX5 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | RGD:737418 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of P2RX5 mRNA | CTD | PMID:20971185 | cyclosporin A | increases expression | ISO | RGD:737418 | 6480464 | Cyclosporine results in increased expression of P2RX5 mRNA | CTD | PMID:20106945 more ... | cyclosporin A | decreases expression | ISO | RGD:737418 | 6480464 | Cyclosporine results in decreased expression of P2RX5 mRNA | CTD | PMID:27989131 | dextran sulfate | multiple interactions | EXP | | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of P2RX5 mRNA | CTD | PMID:29950665 | diclofenac | increases expression | ISO | RGD:620256 | 6480464 | Diclofenac results in increased expression of P2RX5 mRNA | CTD | PMID:30723492 | dorsomorphin | multiple interactions | ISO | RGD:737418 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of P2RX5 mRNA | CTD | PMID:27188386 | doxorubicin | affects expression | ISO | RGD:737418 | 6480464 | Doxorubicin affects the expression of P2RX5 mRNA | CTD | PMID:29803840 | endosulfan | decreases expression | ISO | RGD:620256 | 6480464 | Endosulfan results in decreased expression of P2RX5 mRNA | CTD | PMID:29391264 | entinostat | increases expression | ISO | RGD:737418 | 6480464 | entinostat results in increased expression of P2RX5 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | RGD:737418 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of P2RX5 mRNA | CTD | PMID:27188386 | ethyl methanesulfonate | decreases expression | ISO | RGD:737418 | 6480464 | Ethyl Methanesulfonate results in decreased expression of P2RX5 mRNA | CTD | PMID:23649840 | fenvalerate | increases expression | ISO | RGD:620256 | 6480464 | fenvalerate results in increased expression of P2RX5 mRNA | CTD | PMID:30307764 | formaldehyde | decreases expression | ISO | RGD:737418 | 6480464 | Formaldehyde results in decreased expression of P2RX5 mRNA | CTD | PMID:23649840 | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of P2RX5 mRNA | CTD | PMID:32186404 | indole-3-methanol | multiple interactions | ISO | RGD:620256 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of P2RX5 mRNA | CTD | PMID:22129741 | lead(0) | affects expression | ISO | RGD:737418 | 6480464 | Lead affects the expression of P2RX5 mRNA | CTD | PMID:28903495 | lead(2+) | affects expression | ISO | RGD:737418 | 6480464 | Lead affects the expression of P2RX5 mRNA | CTD | PMID:28903495 | methyl methanesulfonate | decreases expression | ISO | RGD:737418 | 6480464 | Methyl Methanesulfonate results in decreased expression of P2RX5 mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | ISO | RGD:737418 | 6480464 | methylmercuric chloride results in decreased expression of P2RX5 mRNA | CTD | PMID:28001369 | N-acetyl-L-cysteine | multiple interactions | ISO | RGD:620256 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of P2RX5 mRNA | CTD | PMID:22129741 | N-methyl-4-phenylpyridinium | increases expression | ISO | RGD:620256 | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of P2RX5 mRNA | CTD | PMID:28801915 | N-nitrosodiethylamine | increases expression | ISO | RGD:620256 | 6480464 | Diethylnitrosamine results in increased expression of P2RX5 mRNA | CTD | PMID:19638242 | N-nitrosodiethylamine | multiple interactions | ISO | RGD:620256 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of P2RX5 mRNA | CTD | PMID:22129741 | nickel atom | increases expression | ISO | RGD:737418 | 6480464 | Nickel results in increased expression of P2RX5 mRNA | CTD | PMID:25583101 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of P2RX5 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | RGD:737418 | 6480464 | Acetaminophen results in increased expression of P2RX5 mRNA | CTD | PMID:29067470 | phenylephrine | increases expression | ISO | RGD:620256 | 6480464 | Phenylephrine results in increased expression of P2RX5 mRNA | CTD | PMID:18158353 | potassium chromate | increases expression | ISO | RGD:737418 | 6480464 | potassium chromateVI results in increased expression of P2RX5 mRNA | CTD | PMID:22714537 | SB 431542 | multiple interactions | ISO | RGD:737418 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of P2RX5 mRNA | CTD | PMID:27188386 | silicon dioxide | increases expression | ISO | RGD:737418 | 6480464 | Silicon Dioxide analog results in increased expression of P2RX5 mRNA | CTD | PMID:25895662 | sunitinib | decreases expression | ISO | RGD:737418 | 6480464 | Sunitinib results in decreased expression of P2RX5 mRNA | CTD | PMID:31533062 | tamibarotene | increases expression | ISO | RGD:737418 | 6480464 | tamibarotene results in increased expression of P2RX5 mRNA | CTD | PMID:17229644 | tamoxifen | decreases expression | EXP | | 6480464 | Tamoxifen results in decreased expression of P2RX5 mRNA | CTD | PMID:25123088 | titanium dioxide | multiple interactions | EXP | | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of P2RX5 mRNA | CTD | PMID:29950665 | valproic acid | increases methylation | ISO | RGD:737418 | 6480464 | Valproic Acid results in increased methylation of P2RX5 gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | RGD:737418 | 6480464 | Valproic Acid results in increased expression of P2RX5 mRNA | CTD | PMID:23179753 | vincristine | decreases expression | ISO | RGD:737418 | 6480464 | Vincristine results in decreased expression of P2RX5 mRNA | CTD | PMID:23649840 | |